Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer (vol 360, pg 563, 2009)

被引：0
|
作者：
Tol, Jolien
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2010年 / 363卷 / 26期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2573 / 2573
页数：1
相关论文
共 50 条
  • [1] Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
    Tol, Jolien
    Koopman, Miriam
    Cats, Annemieke
    Rodenburg, Cees J.
    Creemers, Geert J. M.
    Schrama, Jolanda G.
    Erdkamp, Frans L. G.
    Vos, Allert H.
    van Groeningen, Cees J.
    Sinnige, Harm A. M.
    Richel, Dirk J.
    Voest, Emile E.
    Dijkstra, Jeroen R.
    Vink-Borger, Marianne E.
    Antonini, Ninja F.
    Mol, Linda
    van Krieken, Johan H. J. M.
    Dalesio, Otilia
    Punt, Cornelis J. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (06): : 563 - 572
  • [2] Cetuximab or bevacizumab in metastatic colorectal cancer?
    Sclafani, Francesco
    Cunningham, David
    [J]. LANCET ONCOLOGY, 2014, 15 (10): : 1040 - 1041
  • [3] Appraisal of bevacizumab and cetuximab for treatment of metastatic colorectal cancer in the UK
    Barnett, David
    Stevens, Andrew
    Longson, Carole
    [J]. LANCET ONCOLOGY, 2006, 7 (10): : 807 - 808
  • [4] COST ANALYSIS OF METASTATIC COLORECTAL CANCER TREATMENT WITH BEVACIZUMAB AND CETUXIMAB
    Maria Vieitez, Jose
    Oyaguez, Itziar
    Angel Casado, Miguel
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v84 - v84
  • [5] Chemotherapy With Bevacizumab for Advanced or Metastatic Colorectal Cancer
    Hirata, Masaru
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S694 - S694
  • [6] Cetuximab after bevacizumab in metastatic colorectal cancer: Is it the best sequence?
    Norguet, Emmanuelle
    Dahan, Laetitia
    Gaudart, Jean
    Gasmi, Mohamed
    Ouafik, L'houcine
    Seitz, Jean-Francois
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 (11) : 917 - 919
  • [7] Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
    Van Cutsem, Eric
    Koehne, Claus-Henning
    Hitre, Erika
    Zaluski, Jerzy
    Chien, Chung-Rong Chang
    Makhson, Anatoly
    D'Haens, Geert
    Pinter, Tamas
    Lim, Robert
    Bodoky, Gyoergy
    Roh, Jae Kyung
    Folprecht, Gunnar
    Ruff, Paul
    Stroh, Christopher
    Tejpar, Sabine
    Schlichting, Michael
    Nippgen, Johannes
    Rougier, Philippe
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (14): : 1408 - 1417
  • [8] Cost of chemotherapy for metastatic colorectal cancer with either bevacizumab or cetuximab: Economic analysis of CALGB/SWOG 80405
    Schrag, Deborah
    Dueck, Amylou C.
    Naughton, Michelle Joy
    Niedzwiecki, Donna
    Earle, Craig
    Shaw, James Edward
    Grothey, Axel
    Hochster, Howard S.
    Blanke, Charles David
    Venook, Alan P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer
    Bai, Long
    Wang, Feng
    Li, Zhe-zhen
    Ren, Chao
    Zhang, Dong-sheng
    Zhao, Qi
    Lu, Yun-xin
    Wang, De-shen
    Ju, Huai-qiang
    Qiu, Miao-zhen
    Wang, Zhi-qiang
    Wang, Feng-hua
    Xu, Rui-hua
    [J]. MEDICINE, 2016, 95 (51) : e4531
  • [10] Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study
    Marques, Rui Pedro
    Godinho, Ana Rita
    Heudtlass, Peter
    Pais, Helena Luna
    Quintela, Antonio
    Martins, Ana Paula
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (05) : 1321 - 1334
12345